Article
Protective effect of the Y220C mutant p53 against steatosis: good news?
Journal of cellular physiology - 1 Sept 2014
Gori Manuele, Barbaro Barbara, Arciello Mario, Maggio Roberta, Viscomi Carmela, Longo Alessia, Balsano Clara
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to steatohepatitis, which may progress to fibrosis, and cirrhosis, leading eventually to hepatocarcinoma development. Recently, cases of hepatocarcinoma have been diagnosed in steatotic patients without nonalcoholic steatohepatitis (NASH) and cirrhosis. The p53 protein, besides its function as tumor suppressor, is emerging as an important...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
